H

Hyundai BioLand Co Ltd
KOSDAQ:052260

Watchlist Manager
Hyundai BioLand Co Ltd
KOSDAQ:052260
Watchlist
Price: 4 150 KRW 0.48% Market Closed
Market Cap: 124.5B KRW

Operating Margin

14.3%
Current
Improving
by 3.8%
vs 3-y average of 10.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.3%
=
Operating Income
₩18B
/
Revenue
₩125.3B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
14.3%
=
Operating Income
₩18B
/
Revenue
₩125.3B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
Hyundai BioLand Co Ltd
KOSDAQ:052260
124.5B KRW
Loading...
FR
L'Oreal SA
PAR:OR
207.1B EUR
Loading...
UK
Unilever PLC
LSE:ULVR
118.7B GBP
Loading...
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.7T INR
Loading...
UK
HALEON PLC
LSE:HLN
34.3B GBP
Loading...
US
Estee Lauder Companies Inc
NYSE:EL
43.1B USD
Loading...
DE
Beiersdorf AG
XETRA:BEI
21.8B EUR
Loading...
JP
Kao Corp
TSE:4452
2.8T JPY
Loading...
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR
Loading...
IN
Dabur India Ltd
NSE:DABUR
932.3B INR
Loading...
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD
Loading...

Market Distribution

Higher than 87% of companies in Korea
Percentile
87th
Based on 2 615 companies
87th percentile
14.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

Hyundai BioLand Co Ltd
Glance View

Market Cap
124.5B KRW
Industry
Consumer products

HYUNDAI BIOLAND Co., Ltd. engages in the manufacture and sale of pharmaceutical and functional products. The company is headquartered in Cheongju, Chungcheongbuk-Do. The company went IPO on 2001-05-17. The firm operates its business through four segments. The Cosmetic Raw Material segment produces products such as portulaca extracts, ulmus extracts, crinum extracts, hyaluronic acids and arbutins. The Pharmaceutical Ingredient segment manufactures and sells products such as phellodendron extracts, ampelopsis extracts and gardenia extracts and others. The Ingredients for Health Functional Food segment produces and distributes red ginseng extract powders, seaweed powders, glucosamine powders, black garlic extract powders, dandelion extract powders, green tea extracts and others. The Medical Device segment involves in the provision of medical equipment such as tissue engineering products, comprised of biological wound dressings and collagen, as well as diagnostic kits, comprised of rapid kits, serological kits and mask packs.

Hyundai BioLand Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
14.3%
=
Operating Income
₩18B
/
Revenue
₩125.3B
What is Hyundai BioLand Co Ltd's current Operating Margin?

The current Operating Margin for Hyundai BioLand Co Ltd is 14.3%, which is above its 3-year median of 10.5%.

How has Operating Margin changed over time?

Over the last 3 years, Hyundai BioLand Co Ltd’s Operating Margin has increased from 9.8% to 14.3%. During this period, it reached a low of 7.2% on Sep 30, 2023 and a high of 14.3% on Oct 30, 2025.

Back to Top